fda glp-1 warning news november 2025 Weight-Loss Drug Demonstration Begins July 2026 September 8, 2025: FDA launches

By Ann Czarnik, M.D., FACEP Board-Certified Emergency Medicine Physician and Co-Founder, Amanecia Health If youre researching GLP-1 weight loss medications , youve probably run into a confusing divide

The enzyme dipeptidyl peptidase-4 (DPP-4) rapidly degrades circulating GLP-1, which is why pharmaceutical versions are chemically modified to resist this breakdown and maintain therapeutic levels for extended periods

Research shows that these medications can improve hormonal profiles by reducing serum testosterone and the free androgen index (FAI)

Short-chain fatty acid receptor and its contribution to glucagon-like peptide-1 release

Takes Time, But It Works Emily R., New York It wasnt instant, and the first few weeks were mostly about adjusting